Weil Gotshal & Manges has closed its second major deal in a month for US private equity client Hicks Muse Tate & Furst after advising the firm on its £93m buy-out of iconic cereal brand, Weetabix.

The recommended deal is expected to see Weil Gotshal installed as primary adviser on a possible flotation of Weetabix, a transaction which could take place as early as next year.